Stuart R. Lipsitz

Stuart R. Lipsitz

Auto-generated profile, based on publicly available information

Stuart R. Lipsitz

Center for Surgery and Public Health, Harvard Medical School Brigham and Women's Hospital Boston Massachusetts USA

Research Focus & Metrics

Academic Career Length

35Years (1992-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 November 2021 in The Joint Commission Journal on Quality and Patient Safety
Verified
Journal Article
Closed access
LRLisa Rotenstein
Lisa Rotenstein
EHElizabeth Harry
Elizabeth Harry
PWPaige Wickner
Paige Wickner
AGAnu Gupte
Anu Gupte
BNBridget A. Neville
Bridget A. Neville
JDJessica Dudley
Jessica Dudley

18 July 2019 in Journal of Medical Internet Research
Verified
Journal Article
Open access
KSKumiko O Schnock
Kumiko O Schnock
JSJulia E Snyder
Julia E Snyder
TFTheresa E Fuller
Theresa E Fuller
MDMegan Duckworth
Megan Duckworth
MGMaxwell Grant
Maxwell Grant
PDPatricia C Dykes
Patricia C Dykes
Journal of Medical Internet Research - International Scientific Journal for Medical Research, Information and Communication on the Internet #Preprint #PeerReviewMe: Warning: This is a unreviewed preprint. Readers are warned that the document has not been peer-reviewed by expert/patient reviewers or an academic editor, may contain misleading claims, and is likely to undergo changes before final publication, if accepted, or may have been rejected/withdrawn. Readers with interest and expertise are encouraged to sign up as peer-reviewer, if the paper is within an open peer-review period. Please cite this preprint only for review purposes or for grant applications and CVs (if you are the author). Background: Health information technology (HIT) tools and patient portals are recognized as a potential mechanism to facilitate patient engagement and patient-centered care, yet the use of these tools remains limited in the hospital setting. While research in this area is growing, it is unclear how the use of acute care patient portals and patient-centered HIT tools might affect outcomes such as patient activation. Objective: The aim was to describe use of an acute care patient portal and investigate the association of HIT tools in the inpatient setting with patient and care partner activation. Methods: We implemented a suite of electronic tools including a patient portal, bedside safety display, and provider-facing safety dashboard on six acute care units over an 18-month period. We compared patient characteristics of those that enrolled to the patient portal and those that declined. Patient and care partner use of the portal was evaluated, and patient and care partner activation was assessed using the short-form of the Patient Activation Measure. Results: 1,755 (59%) agreed to participate and use the patient portal. Patients that declined were older, sicker, more likely to have Medicare as their insurer, and less likely to use the enterprise patient portal. The most used features of the patient portal were the laboratory test results, care team information, and medications list. Most users accessed the portal between 1-4 days (range 1-32 days) during their hospitalization, and the average number of days used (logged in at least once per day) was 1.8 days. On average, users accessed the portal 42.7% of the hospital days it was available. There was significant improvement in patient activation on the neurology service (P <.0001) and medicine service (P = .01) after the introduction of patient and provider-facing HIT tools and use of a patient portal, but not on the oncology service. Conclusions: We found an association between use of patient and provider-facing HIT tools including a patient portal and improved levels of patient activation in inpatients. These tools may help facilitate patient engagement and improve outcomes. Future work should leverage usage metrics to describe inpatient portal use and assess the impact of HIT tools on specific outcome measures in the hospital setting.

1 May 2024 in JAMA Network Open
Verified
Journal Article
Open access
PDF file
JRJorge A. Rodriguez
Jorge A. Rodriguez
EKElaine C. Khoong
Elaine C. Khoong
SLStuart R. Lipsitz
Stuart R. Lipsitz
CLCourtney Rees Lyles
Courtney Rees Lyles
DBDavid W. Bates
David W. Bates
LSLipika Samal
Lipika Samal
Patients with limited English proficiency (LEP) face disparities in using telehealth.1 While research has focused on access, attention to patient experience is essential. Patients with LEP have worse experience with in-person care.2 We examined differences in telehealth access and experience between patients with LEP and patients with English proficiency (EP) in California.

17 April 2021 in Biometrics
Verified
Journal Article
Closed access
PDF file
PBPiyali Basak
Piyali Basak
ALAntonio Linero
Antonio Linero
DSDebajyoti Sinha
Debajyoti Sinha
SLStuart Lipsitz
Stuart Lipsitz

11 January 2019 in Cancer
Verified
Journal Article
Open access
PDF file
ACAlexander P. Cole
Alexander P. Cole
SFSean A. Fletcher
Sean A. Fletcher
SBSebastian Berg
Sebastian Berg
Junaid NabiJunaid Nabi
Junaid Nabi
BMBrandon A. Mahal
Brandon A. Mahal
MLMuhieddine Labban
Muhieddine Labban
Background: There are race‐based differences in bladder cancer survival. To better understand this phenomenon, this study was designed to assess the statistical contributions of tumor, treatment, and access variables to race‐based differences in survival. Methods: Data were extracted from the National Cancer Data Base on black and white adults with muscle‐invasive bladder cancer from 2004 to 2015. The impact of tumor, access, and treatment variables on differences in survival was inferred by the performance of sequential propensity score–weighted analyses in which black and white patients were balanced with respect to demographics and health status (comorbidities) tumor characteristics, treatment, and access‐related variables. The propensity score–weighted hazard of death (black vs white) was calculated after each iteration. Results: This study identified 44,577 patients with a median follow‐up of 77 months. After demographics and health status were balanced, black race was associated with 18% worse mortality (hazard ratio, 1.18; 95% confidence interval [CI], 1.12‐1.25; P < .001). Balancing by tumor characteristics reduced this to 16%, balancing by treatment reduced this to 10%, and balancing by access‐related variables resulted in no difference. Access‐related variables explained 40% (95% CI, 22.9%‐57.0%) of the excess risk of death in blacks, whereas treatment factors explained 35% (95% CI, 22.2%‐46.9%). The contribution of tumor characteristics was not significant. Conclusions: In the models, differences in survival for black and white patients with bladder cancer are best explained by disparities in access and treatment, not tumor characteristics. Access to care is likely a key factor in racial disparities in cancer.

13 April 2016 in Journal of Medical Internet Research
Verified
Journal Article
Open access
SESrinivas Emani
Srinivas Emani
MHMichael Healey
Michael Healey
DTDavid Y Ting
David Y Ting
SLStuart R Lipsitz
Stuart R Lipsitz
HRHarley Ramelson
Harley Ramelson
DBDave Bates
Dave Bates
Journal of Medical Internet Research - International Scientific Journal for Medical Research, Information and Communication on the Internet